SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 267 filers reported holding SELECT MED HLDGS CORP in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $878 | -20.7% | 34,738 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $1,107 | +30.1% | 34,738 | +5.5% | 0.01% | +22.2% |
| Q1 2023 | $851 | +4.2% | 32,925 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $817 | -99.9% | 32,925 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $727,000 | -2.4% | 32,925 | +6.0% | 0.01% | +28.6% |
| Q1 2022 | $745,000 | -18.4% | 31,060 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $913,000 | -18.7% | 31,060 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $1,123,000 | -14.5% | 31,060 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,313,000 | +24.0% | 31,060 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $1,059,000 | +23.3% | 31,060 | 0.0% | 0.01% | +11.1% |
| Q4 2020 | $859,000 | +32.8% | 31,060 | 0.0% | 0.01% | +28.6% |
| Q3 2020 | $647,000 | +41.3% | 31,060 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $458,000 | +13.4% | 31,060 | +15.2% | 0.01% | -16.7% |
| Q1 2020 | $404,000 | -39.2% | 26,960 | -5.3% | 0.01% | -14.3% |
| Q4 2019 | $664,000 | +40.7% | 28,460 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $472,000 | +4.4% | 28,460 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $452,000 | +12.7% | 28,460 | 0.0% | 0.01% | +20.0% |
| Q1 2019 | $401,000 | -8.2% | 28,460 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $437,000 | -16.6% | 28,460 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $524,000 | -3.3% | 28,460 | -4.7% | 0.01% | 0.0% |
| Q2 2018 | $542,000 | +5.2% | 29,860 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $515,000 | -9.3% | 29,860 | -7.3% | 0.01% | -14.3% |
| Q4 2017 | $568,000 | -8.1% | 32,200 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $618,000 | +17.3% | 32,200 | -6.1% | 0.01% | 0.0% |
| Q2 2017 | $527,000 | -7.7% | 34,300 | -19.9% | 0.01% | 0.0% |
| Q1 2017 | $571,000 | +0.7% | 42,800 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $567,000 | +3.3% | 42,800 | +5.2% | 0.01% | 0.0% |
| Q3 2016 | $549,000 | +34.9% | 40,700 | +8.8% | 0.01% | +40.0% |
| Q2 2016 | $407,000 | -3.8% | 37,400 | +4.5% | 0.01% | 0.0% |
| Q1 2016 | $423,000 | -0.7% | 35,800 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $426,000 | +10.4% | 35,800 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $386,000 | -33.4% | 35,800 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $580,000 | +9.2% | 35,800 | 0.0% | 0.01% | +16.7% |
| Q1 2015 | $531,000 | – | 35,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 213,703 | $5,524,223 | 5.60% |
| Camber Capital Management LP | 4,800,000 | $124,080 | 3.82% |
| Hood River Capital Management LLC | 2,693,137 | $69,618,000 | 2.25% |
| Smith, Graham & Co., Investment Advisors, LP | 434,878 | $11,241,596 | 1.37% |
| Sivik Global Healthcare LLC | 107,838 | $2,788 | 1.20% |
| Capital Impact Advisors, LLC | 33,173 | $857,522 | 1.05% |
| DENALI ADVISORS LLC | 85,772 | $2,217,206 | 0.92% |
| CLOUGH CAPITAL PARTNERS L P | 297,500 | $7,690,375 | 0.83% |
| Huber Capital Management LLC | 127,603 | $3,298,537 | 0.82% |
| Nebula Research & Development LLC | 12,442 | $321,626 | 0.57% |